Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial
Tremor and Other Hyperkinetic Movements · 2023
DOI: 10.5334/tohm.798 ↗Kurz gefasst
Pragmatische Studie in der Zeitschrift Tremor and Other Hyperkinetic Movements, 2023. Verfasst von Dingwei Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: CVS Health Clinical Trial Services LLC, Woonsocket, RI, USA. Hauptthemen laut MEDLINE: Essential Tremor. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transcutaneous afferent patterned stimulation (TAPS) is a wrist-worn, non-invasive therapy delivering calibrated stimulation to the median and radial nerves. While the efficacy and safety of TAPS therapy for essential tremor (ET) have been demonstrated, current evidence supporting therapeutic benefits of TAPS versus standard of care (SOC) is lacking. This prospective study evaluated the clinical benefit of adding TAPS treatment to SOC versus SOC alone.
Methods
This randomized, controlled, pragmatic trial recruited patients from a large health plan’s Commercially Insured and Medicare Advantage population. 310 patients were randomized 1:1 to one month of treatment with TAPS (TX) or standard of care (SOC). The pre-specified endpoints were changes in tremor power measured by motion sensors (primary) and improvement in Bain & Findley Activities of Daily Living (BF-ADL) upper limb scores reported (secondary) between TX and SOC at one month.
Results
276 patients completed the one-month endpoints (n=133 TX, n=143 SOC). The study met the primary and secondary endpoints, with significantly reduced tremor power in TX than SOC (0.017 (0.003) versus 0.08 (0.014) (m/s2)2; geometric mean (SE); p < 0.0001) and greater improvement in the BF-ADL score in TX than SOC (1.6 (0.43) vs 0.2 (0.37) points; mean (SE); p < 0.05). 82% of TX patients experienced tremor improvement from before to after therapy. No serious device-related adverse events were reported.
Discussion
This trial demonstrates that TAPS significantly improves tremor power and BF-ADLs in patients with ET compared to SOC over one month of home use. Highlights This study found that TAPS significantly improves tremor power and BF-ADL scores in patients with ET compared to SOC over one month of home use. This real-world study suggests that non-invasive TAPS therapy is a safe and valuable treatment option for patients with ET.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CVS Health Clinical Trial Services LLC, Woonsocket, RI, USA.
- Cala Health, Inc., San Mateo, CA, USA.
ORCID-Profile: Dingwei Dai, Joaquim Fernandes, Han Kim
Zitieren
APA
Dai, D., Fernandes, J., Kim, H., & Coetzer, H. (2023). Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.798
Vancouver
Dai D, Fernandes J, Kim H, Coetzer H. Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial. Tremor and Other Hyperkinetic Movements. 2023. doi:10.5334/tohm.798
BibTeX
@article{Dai2023,
author = {Dai, Dingwei and Fernandes, Joaquim and Kim, Han and Coetzer, Henriette},
title = {Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial},
journal = {Tremor and Other Hyperkinetic Movements},
year = {2023},
doi = {10.5334/tohm.798}
}
EUVIMED